Medipixel XA-Assisted PCI in Coronary Artery Disease

NARecruitingINTERVENTIONAL
Enrollment

830

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions
Percutaneous Coronary Intervention (PCI)Coronary Arterial Disease (CAD)
Interventions
PROCEDURE

Medipixel XA-Assisted Percutaneous Coronary Intervention

"Medipixel XA-Assisted Percutaneous Coronary Intervention (MPXA-PCI) is an AI-assisted coronary intervention procedure utilizing Medipixel XA (MPXA), an artificial intelligence-based quantitative coronary analysis (AI-QCA) software. MPXA analyzes angiographic images in real-time to assist in lesion assessment, optimal balloon and stent selection, and procedural decision-making during percutaneous coronary intervention (PCI).~In this study, all participants will undergo MPXA-assisted PCI, where the software provides automated vessel segmentation, diameter measurement, and lesion quantification to optimize procedural outcomes. Operators will follow a predefined protocol incorporating MPXA measurements for balloon sizing, stent selection, and post-dilation strategies.~The study evaluates the safety, feasibility, and clinical impact of MPXA-assisted PCI in real-world coronary artery disease patients."

Trial Locations (6)

13496

RECRUITING

CHA Bundang Medical Center, Seongnam-si

14351

RECRUITING

Chung-Ang University Gwangmyeong Hospital, Gwangmyeong

42601

RECRUITING

Keimyung University Dongsan Medical Center, Daegu

44033

RECRUITING

Ulsan University Hospital, Ulsan

54987

RECRUITING

Presbyterian Medical Center, Jeonju

61469

RECRUITING

Chonnam National University Hospital, Gwangju

All Listed Sponsors
lead

CHA University

OTHER